Long-term neck control rates after complete response to chemoradiation in patients with advanced head and neck cancer

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 31, Issue 5, 2008, Pages 465-469

  Rengan, Ramesh ^a,b   Pfister, David G ^a   Lee, Nancy Y ^a,b   Kraus, Dennis H ^a   Shah, Jatin P ^a   Shaha, Ashok R ^a   Ben Porat, Leah S ^a   Zelefsky, Michael J ^a,b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Chemoradiation; Head and neck cancer; Neck dissection; Organ preservation

Indexed keywords

BLEOMYCIN; CISPLATIN;

ADVANCED CANCER; ARTICLE; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; DRUG MEGADOSE; DRUG RESPONSE; FOLLOW UP; HEAD AND NECK CANCER; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; TREATMENT FAILURE;

ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; HEAD AND NECK NEOPLASMS; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; NEOPLASM STAGING; RADIOTHERAPY DOSAGE; REMISSION INDUCTION; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 55249110644     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/COC.0b013e31816a6208     Document Type: Article

References (33)

1. Barkley HT Jr, Fletcher GH, Jesse RH, et al. Management of cervical lymph node metastases in squamous cell carcinoma of the tonsillar fossa, base of tongue, supraglottic larynx, and hypopharynx. Am J Surg. 1972;124:462-467.
2. Mendenhall WM, Villaret DB, Amdur RJ, et al. Planned neck dissection after definitive radiotherapy for squamous cell carcinoma of the head and neck. Head Neck. 2002;24:1012-1018.
3. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. The Department of Veterans Affairs Laryngeal Cancer Study Group. N Engl J Med. 1991;324:1685-1690.
4. Al-Sarraf M, LeBlanc M, Giri PG, et al. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized intergroup study 0099. J Clin Oncol. 1998;16:1310-1317.
5. Brizel DM, Albers ME, Fisher SR, et al. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med. 1998;338:1798-1804.
6. Calais G, Alfonsi M, Bardet E, et al. [Stage III and IV cancers of the oropharynx: results of a randomized study of Gortec comparing radiotherapy alone with concomitant chemotherapy]. Bull Cancer. 2000;87:48-53.
7. Forastiere AA, Goepfert H, Maor M, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med. 2003;349:2091-2098.
8. Jeremic B, Shibamoto Y, Milicic B, et al. Hyperfractionated radiation therapy with or without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: a prospective randomized trial. J Clin Oncol. 2000;18:1458-1464.
9. Kutler DI, Patel SG, Shah JP. The role of neck dissection following definitive chemoradiation. Oncology (Williston Park). 2004;18:993-998; discussion, 999, 1003-1004, 1007.
10. Pellitteri PK, Ferlito A, Rinaldo A, et al. Planned neck dissection following chemoradiotherapy for advanced head and neck cancer is it necessary for all? The role of neck dissection following definitive chemoradiation. Head Neck. 2006;28:166-175.
11. McHam SA, Adelstein DJ, Rybicki LA, et al. Who merits a neck dissection after definitive chemoradiotherapy for N2-N3 squamous cell head and neck cancer? Head Neck. 2003;25:791-798.
12. Mabanta SR, Mendenhall WM, Stringer SP, et al. Salvage treatment for neck recurrence after irradiation alone for head and neck squamous cell carcinoma with clinically positive neck nodes. Head Neck. 1999;21:591-594.
13. Brizel DM, Prosnitz RG, Hunter S, et al. Necessity for adjuvant neck dissection in setting of concurrent chemoradiation for advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2004;58:1418-1423.
14. Pletcher SD, Kaplan MJ, Eisele DW, et al. Management of cervical metastases in advanced squamous cell carcinoma of the base of tongue. Arch Otolaryngol Head Neck Surg. 2003;129:983-986.
15. Armstrong J, Pfister D, Strong E, et al. The management of the clinically positive neck as part of a larynx preservation approach. Int J Radiat Oncol Biol Phys. 1993;26:759-765.
16. Pfister DG, Bajorin D, Motzer R, et al. Cisplatin, fluorouracil, and leucovorin. Increased toxicity without improved response in squamous cell head and neck cancer. Arch Otolaryngol Head Neck Surg. 1994;120:89-95.
17. Pfister DG, Harrison LB, Strong EW, et al. Organ-function preservation in advanced oropharynx cancer: results with induction chemotherapy and radiation. J Clin Oncol. 1995;13:671-680.
18. Beahrs O, Henson D, Hutter R, et al, eds. American Joint Committee on Cancer: Manual for Staging of Cancer. 3rd ed. New York, NY: J. B. Lippincott Company; 1988:33-45.
19. Harrison LB, Pfister DG, Fass DE, et al. Concomitant chemotherapy- radiation therapy followed by hyperfractionated radiation therapy for advanced unresectable head and neck cancer. Int J Radiat Oncol Biol Phys. 1991;21:703-708.
20. Gray R. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat. 1988;16:1141-1154.
21. Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999;94:496-509.
22. Kaplan EL, Meier P. Nonparametric estimations for incomplete observations. J Am Stat Assoc. 1958;53:457.
23. Peto R, Peto J. Asymptomatically efficient rank invariant test procedures. J R Stat Soc Series A. 1972;135:185-206.
24. Liauw SL, Amdur RJ, Morris CG, et al. Isolated neck recurrence after definitive radiotherapy for node-positive head and neck cancer: salvage in the dissected or undissected neck. Head Neck. 2007;29:715-719.
25. Soltys SG, Suen A, Fee W, et al. Is a planned neck dissection necessary after chemoradiotherapy in head and neck cancer patients with advanced nodal stage. Int J Radiat Oncol Biol Phys. 2004;60:S495.
26. Vongtama R, Lee M, Kim B, et al. Early nodal response as a predictor for necessity of functional neck dissection after chemoradiation. Cancer J. 2004;10:339-342.
27. Mendenhall WM, Parsons JT. Management of the neck and unknown primary site. 1st ed. Philadelphia, PA: Churchill Livingstone; 2000:549-563.
28. Rogers JW, Greven KM, McGuirt WF, et al. Can post-RT neck dissection be omitted for patients with head-and-neck cancer who have a negative PET scan after definitive radiation therapy? Int J Radiat Oncol Biol Phys. 2004;58:694-697.
29. Ensley JF, Jacobs JR, Weaver A, et al. Correlation between response to cisplatinum-combination chemotherapy and subsequent radiotherapy in previously untreated patients with advanced squamous cell cancers of the head and neck. Cancer. 1984;54:811-814.
30. Hong WK, Bromer RH, Amato DA, et al. Patterns of relapse in locally advanced head and neck cancer patients who achieved complete remission after combined modality therapy. Cancer. 1985;56:1242-1245.
31. Spaulding MB, Fischer SG, Wolf GT. Tumor response, toxicity, and survival after neoadjuvant organ-preserving chemotherapy for advanced laryngeal carcinoma. The Department of Veterans Affairs Cooperative Laryngeal Cancer Study Group. J Clin Oncol. 1994;12:1592-1599.
32. Urba S, Wolf G, Eisbruch A, et al. Single-cycle induction chemotherapy selects patients with advanced laryngeal cancer for combined chemoradiation: a new treatment paradigm. J Clin Oncol. 2006;24:593-598.
33. Eisbruch A, Thornton AF, Urba S, et al. Chemotherapy followed by accelerated fractionated radiation for larynx preservation in patients with advanced laryngeal cancer. J Clin Oncol. 1996;14:2322-2330.